Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saravanan Vijayakumar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bioinformation|February 26, 2016
Mammalian Mitochondrial ncRNA DatabaseShanmugam Anandakumar, Saravanan Vijayakumar, Nagarajan Arumugam, et al.
Cancer Epidemiology|December 17, 2025
Understanding female breast cancer risk in the Indian population: Evidence from a systematic review and meta-analysisSaravanan Vijayakumar, Thilagavathi Ramamoorthy, Abhishek David George, et al.
Mini Reviews in Medicinal Chemistry|September 8, 2023
The Application of MD Simulation to Lead Identification, Vaccine Design, and Structural Studies in Combat against Leishmaniasis - A ReviewSaravanan Vijayakumar, Lukkani Laxman Kumar, Subhomoi Borkotoky, et al.
Molecular Biosystems|October 7, 2014
Quercetin 3-O-rutinoside mediated inhibition of PBP2a: computational and experimental evidence to its anti-MRSA activityNidhi Rani, Saravanan Vijayakumar, Lakshmi Palanisamy Thanga Velan, et al.
Journal of Biomolecular Structure & Dynamics|September 12, 2015
Allosteric site-mediated active site inhibition of PBP2a using Quercetin 3-O-rutinoside and its combinationNidhi Rani, Saravanan Vijayakumar, Lakshmi P T V, et al.
Journal of Biomolecular Structure & Dynamics|December 12, 2018
Validation of NAD synthase inhibitors for inhibiting the cell viability of <i>Leishmania donovani</i>: <i>In silico</i> and <i>in vitro</i> approachHaraprasad Mandal, Saravanan Vijayakumar, Shalini Yadav, et al.
Parasitology Research|May 10, 2022
In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferaseVishnu Kant, Pawan Kumar, Ravi Ranjan, et al.
Journal of Gastrointestinal Cancer|December 29, 2025
Risk Factors and Clinical Predictors Associated with Incidental Gallbladder Cancer: A Systematic Review and Meta-AnalysisThilagavathi Ramamoorthy, Vaitheeswaran Kulothungan, Saravanan Vijayakumar, et al.
Experimental Parasitology|February 13, 2024
A review of non-invasive samples and tools in kala-azar diagnosis and test of cureSaravanan Vijayakumar, Priyanka Kriti Narayan, Shobha Kumari, et al.
Journal of Biomolecular Structure & Dynamics|February 9, 2018
In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS)Vishnu Kant, Saravanan Vijayakumar, Ganesh Chandra Sahoo, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bioinformation|February 26, 2016
Mammalian Mitochondrial ncRNA DatabaseShanmugam Anandakumar, Saravanan Vijayakumar, Nagarajan Arumugam, et al.
Cancer Epidemiology|December 17, 2025
Understanding female breast cancer risk in the Indian population: Evidence from a systematic review and meta-analysisSaravanan Vijayakumar, Thilagavathi Ramamoorthy, Abhishek David George, et al.
Mini Reviews in Medicinal Chemistry|September 8, 2023
The Application of MD Simulation to Lead Identification, Vaccine Design, and Structural Studies in Combat against Leishmaniasis - A ReviewSaravanan Vijayakumar, Lukkani Laxman Kumar, Subhomoi Borkotoky, et al.
Molecular Biosystems|October 7, 2014
Quercetin 3-O-rutinoside mediated inhibition of PBP2a: computational and experimental evidence to its anti-MRSA activityNidhi Rani, Saravanan Vijayakumar, Lakshmi Palanisamy Thanga Velan, et al.
Journal of Biomolecular Structure & Dynamics|September 12, 2015
Allosteric site-mediated active site inhibition of PBP2a using Quercetin 3-O-rutinoside and its combinationNidhi Rani, Saravanan Vijayakumar, Lakshmi P T V, et al.
Journal of Biomolecular Structure & Dynamics|December 12, 2018
Validation of NAD synthase inhibitors for inhibiting the cell viability of <i>Leishmania donovani</i>: <i>In silico</i> and <i>in vitro</i> approachHaraprasad Mandal, Saravanan Vijayakumar, Shalini Yadav, et al.
Parasitology Research|May 10, 2022
In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferaseVishnu Kant, Pawan Kumar, Ravi Ranjan, et al.
Journal of Gastrointestinal Cancer|December 29, 2025
Risk Factors and Clinical Predictors Associated with Incidental Gallbladder Cancer: A Systematic Review and Meta-AnalysisThilagavathi Ramamoorthy, Vaitheeswaran Kulothungan, Saravanan Vijayakumar, et al.
Experimental Parasitology|February 13, 2024
A review of non-invasive samples and tools in kala-azar diagnosis and test of cureSaravanan Vijayakumar, Priyanka Kriti Narayan, Shobha Kumari, et al.
Journal of Biomolecular Structure & Dynamics|February 9, 2018
In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS)Vishnu Kant, Saravanan Vijayakumar, Ganesh Chandra Sahoo, et al.
Pageof 3